15:01:08 EDT Mon 16 Sep 2024
Enter Symbol
or Name
USA
CA



Compass Venture Inc
Symbol CVI
Shares Issued 10,603,325
Recent Sedar Documents

Compass Venture shareholders approve all matters at AGM

2024-07-12 15:44 ET - News Release

Subject: Compass Venture Inc. - News Release PDF Document

File: Attachment 2024-07-12 Compass NR - 2024 AGM NR.pdf

COMPASS VENTURE INC. 1 North Bridge Road, #02-07 High Street Centre,

Singapore 179094

COMPASS VENTURE ANNOUNCES RESULTS OF 2024 ANNUAL GENERAL MEETING

July 12, 2024 Vancouver, British Columbia Compass Venture Inc. (the "Company" or "Compass") announces that all matters submitted to shareholders for approval as set out in detail in the Company's management information circular ("Circular") dated May 13, 2024 were approved at the annual general meeting of the shareholders of the Company held on June 26, 2024 (the "Meeting"). At the Meeting, Manning Elliott LLP was appointed as the auditor of the Company and the incumbent members of the board of directors, being Dr. Kah Meng Lim, Joshua Siow and Patricia Chow were elected.

In addition to the above, ordinary resolutions of the shareholders were also passed at the Meeting to (i) approve the amendments of the Company's stock option plan in order to comply with the new policies of the TSX Venture Exchange and (ii) approve the adoption of an RSU plan.

Please refer to the Circular for further details with respect to the amendments of the Company's stock option plan.

About the Company

The Company is a capital pool company pursuant to Policy 2.4 of the Exchange. Except as specifically contemplated in such policy, until the completion of its Qualifying Transaction, the Company will not carry on business, other than the identification and evaluation of companies, businesses or assets with a view to completing a proposed Qualifying Transactions. Investors are cautioned that trading in the securities of a capital pool company is considered highly speculative.

For further information, please contact:

Dr. Kah Meng Lim, Chief Executive Officer

Telephone: (65) 6842 1142

E-mail: kmlim@geneoasis.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

© 2024 Canjex Publishing Ltd. All rights reserved.